Business
Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets
Toronto, Ontario--(Newsfile Corp. - May 5, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF...
About this update from Therma Bright Inc.
[{"type":"text","content":"Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular MarketsToronto, Ontario--(Newsfile Corp. - May 5, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) (\"Therma\" or the \"Company\"), a developer and investment partner specializing in advanced medical device technologies, is pleased to announce that Horizon Health (\"Horizon\") has purchased an additional 100 Venowave™ units. This second commercial order follows the rapid deployment and clinical success of the initial 100-unit shipment delivered to Horizon in late March 2026.The decision by Horizon Health to double its initial commitment underscores the strong demand for the Venowave™ mobile compression device within Horizon's extensive vascular patient population. By leveraging Horizon's established distribution channels, the technology has reached patients requiring effective, mobile solutions for circulation and DVT prevention with seamless integration.Rob Fia, CEO of Therma Bright commented: \"Seeing Horizon Health return so quickly for a second order validates our belief that Venowave™ is a superior solution for vascular patients. This follow-on purchase confirms that our distribution strategy is working, and we are now focused on supporting Horizon as they continue to scale these volumes across their network.\"Steve Ebner, Co-CEO, commented: \"The feedback from our distribution channels for the first 100 Venowave™ units has been exceptional. Our clinical teams and patients have reported high satisfaction with the device's performance and ease of use.\"James Stadler Co-CEO of Horizon Health commented: \"The initial success we've seen with our vascular patient base has been a primary driver for this second order. Based on the positive outcomes and the efficiency of our current distribution channels, we anticipate a potential ramp-up in order frequency and volume as we move through the remainder of the year.\" Commercial OutlookWith Horizon Health currently moving over 35,000 compression products annually, Therma Bright views these consecutive 100-unit orders as the foundation for a significant long-term revenue stream. Both companies are working closely to monitor patient outcomes and supply chain efficiency to support a projected increase in order sizes as Venowave™ ...